Thomas Knightly, MD
Psychiatry · Stamford, CTNPI 1447771282
Payments from drug & device makers
What this record shows
15 manufacturers reported payments, led by Brainsway USA Inc at 53.0% of the total. Among psychiatry clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 96 payments — averaging $59.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Brainsway USA Inc$3K
- Johnson & Johnson$936
- AbbVie$427
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$399
- Teva Pharmaceuticals USA, Inc.$136
- Otsuka America Pharmaceutical, Inc.$121
- plus $684 from 9 others
What the payments were for
- Speaking & faculty fees$3,00052%
- Food & beverage$2,75048%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Brainsway USA Inc | 2 | $3,049 |
| Johnson & Johnson | 20 | $936 |
| AbbVie | 18 | $427 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 14 | $399 |
| Teva Pharmaceuticals USA, Inc. | 6 | $136 |
| Otsuka America Pharmaceutical, Inc. | 5 | $121 |
| Corium, LLC | 6 | $107 |
| Neurocrine Biosciences, Inc. | 5 | $99 |
| Tris Pharma Inc | 5 | $99 |
| Alkermes, Inc. | 3 | $80 |
| Supernus Pharmaceuticals, Inc. | 3 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $74 |
| Vanda Pharmaceuticals Inc. | 3 | $71 |
| E.r. Squibb & Sons, L.L.C. | 2 | $55 |
| Axsome Therapeutics, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Brainsway Deep TMS$3,000
- SPRAVATO$274
- CAPLYTA$127
- VRAYLAR$125
How this compares
$5,750 in reported general payments places this provider in the 90th percentile of 644 psychiatry providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Stamford
- F MuellerStamford$8K
- Vladimir CoricNew Haven$133.7M
- Donald AmmermanDanbury$1.5M
- Joseph GoldbergNew Canaan$914K
- Lisa HardingMilford$608K
- Tarique PereraDanbury$383K
- John GelinasDanbury$364K
- Irene AbramovichWest Hartford$352K
- Robert BermanNew Haven$126K
- John KrystalWest Haven$122K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.